These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16447748)

  • 41. Alzheimer's congress. Further progress on a beta-amyloid vaccine.
    Helmuth L
    Science; 2000 Jul; 289(5478):375. PubMed ID: 10939941
    [No Abstract]   [Full Text] [Related]  

  • 42. Polypeptide conjugates comprising a beta-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease.
    Manea M; Mezö G; Hudecz F; Przybylski M
    Biopolymers; 2004; 76(6):503-11. PubMed ID: 15499564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.
    Masliah E; Hansen L; Adame A; Crews L; Bard F; Lee C; Seubert P; Games D; Kirby L; Schenk D
    Neurology; 2005 Jan; 64(1):129-31. PubMed ID: 15642916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intramuscular delivery of a single chain antibody gene reduces brain Abeta burden in a mouse model of Alzheimer's disease.
    Wang YJ; Pollard A; Zhong JH; Dong XY; Wu XB; Zhou HD; Zhou XF
    Neurobiol Aging; 2009 Mar; 30(3):364-76. PubMed ID: 17686552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clearing tau pathology with Abeta immunotherapy--reversible and irreversible stages revealed.
    Hutton M; McGowan E
    Neuron; 2004 Aug; 43(3):293-4. PubMed ID: 15294135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease.
    Wang CY; Finstad CL; Walfield AM; Sia C; Sokoll KK; Chang TY; Fang XD; Hung CH; Hutter-Paier B; Windisch M
    Vaccine; 2007 Apr; 25(16):3041-52. PubMed ID: 17287052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody therapy for Alzheimer's disease.
    Morgan D
    Expert Rev Vaccines; 2003 Feb; 2(1):53-9. PubMed ID: 12901597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vaccine therapy for Alzheimer's disease].
    Hara H
    Nihon Rinsho; 2004 Apr; 62 Suppl 4():254-8. PubMed ID: 15174680
    [No Abstract]   [Full Text] [Related]  

  • 50. Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model.
    Okura Y; Kohyama K; Park IK; Matsumoto Y
    J Neuropathol Exp Neurol; 2008 Nov; 67(11):1063-71. PubMed ID: 18957895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization with amyloid-beta using GM-CSF and IL-4 reduces amyloid burden and alters plaque morphology.
    DaSilva K; Brown ME; Westaway D; McLaurin J
    Neurobiol Dis; 2006 Aug; 23(2):433-44. PubMed ID: 16766202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunotherapy for Alzheimer's disease: attacking amyloid-beta from the inside.
    Arbel M; Solomon B
    Trends Immunol; 2007 Dec; 28(12):511-3. PubMed ID: 17981084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
    Schenk DB; Seubert P; Grundman M; Black R
    Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alzheimer's cure?
    Schub T
    Lab Anim (NY); 2001 Apr; 30(4):12. PubMed ID: 11385737
    [No Abstract]   [Full Text] [Related]  

  • 56. Alzheimer's disease. Antibody clears senile plaques.
    St George-Hyslop PH; Westaway DA
    Nature; 1999 Jul; 400(6740):116-7. PubMed ID: 10408433
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD.
    Bayer AJ; Bullock R; Jones RW; Wilkinson D; Paterson KR; Jenkins L; Millais SB; Donoghue S
    Neurology; 2005 Jan; 64(1):94-101. PubMed ID: 15642910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis.
    Lee EB; Leng LZ; Lee VM; Trojanowski JQ
    FEBS Lett; 2005 May; 579(12):2564-8. PubMed ID: 15862291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta).
    Gandy S; DeMattos RB; Lemere CA; Heppner FL; Leverone J; Aguzzi A; Ershler WB; Dai J; Fraser P; St George Hyslop P; Holtzman DM; Walker LC; Keller ET
    Mech Ageing Dev; 2004 Feb; 125(2):149-51. PubMed ID: 15037022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.
    Hock C; Konietzko U; Papassotiropoulos A; Wollmer A; Streffer J; von Rotz RC; Davey G; Moritz E; Nitsch RM
    Nat Med; 2002 Nov; 8(11):1270-5. PubMed ID: 12379846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.